Literature DB >> 11311994

Cubic phase gels as drug delivery systems.

J C Shah1, Y Sadhale, D M Chilukuri.   

Abstract

Lipids have been used extensively for drug delivery in various forms such as liposomes, and solid-matrices. The focus of this review is evaluation of liquid crystalline cubic phases, spontaneously formed when amphiphilic lipids are placed in aqueous environment, for drug delivery. Cubic phases have an interesting thermodynamically stable structure consisting of curved bicontinuous lipid bilayer in three dimensions, separating two congruent networks of water channels. The unique structure of cubic phase has been extensively studied using various spectroscopic techniques and their resemblance to biomembranes has prompted many scientists to study behavior of proteins in cubic phases. The ability of cubic phase to incorporate and control release of drugs of varying size and polar characteristics, and biodegradability of lipids make it an interesting drug delivery system for various routes of administration. Cubic phases have been shown to deliver small molecule drugs and large proteins by oral and parenteral routes in addition to local delivery in vaginal and periodontal cavity. A number of different proteins in cubic phase appear to retain their native conformation and bioactivity, and are protected from chemical and physical inactivation perhaps due to the reduced activity of water and biomembrane-like structure of cubic phase. Release of drugs from cubic phase typically show diffusion controlled release from a matrix as indicated by Higuchi's square root of time release kinetics. Incorporation of drug in cubic phase can cause phase transformation to lamellar or reversed hexagonal phase depending on the polarity and concentration of the drug, which may affect the release profile. Biodegradability, phase behavior, ability to deliver drugs of varying sizes and polarity and the ability to enhance the chemical and/or physical stability of incorporated drugs and proteins make the cubic phase gel an excellent candidate for use as a drug delivery matrix. However, shorter release duration and the extremely high viscosity may limit its use to specific applications such as periodontal, mucosal, vaginal and short acting oral and parenteral drug delivery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311994     DOI: 10.1016/s0169-409x(01)00108-9

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  50 in total

1.  Lipid-based supramolecular systems for topical application: a preformulatory study.

Authors:  Elisabetta Esposito; Nadia Eblovi; Silvia Rasi; Markus Drechsler; Giordano M Di Gregorio; Enea Menegatti; Rita Cortesi
Journal:  AAPS PharmSci       Date:  2003-11-18

2.  Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.

Authors:  Di Bei; Tao Zhang; James B Murowchick; Bi-Botti C Youan
Journal:  AAPS PharmSciTech       Date:  2010-08-06       Impact factor: 3.246

3.  Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A.

Authors:  Luciana B Lopes; Denise A Ferreira; Daniel de Paula; M Tereza J Garcia; José A Thomazini; Márcia C A Fantini; M Vitória L B Bentley
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

4.  Development of tetracycline-serratiopeptidase-containing periodontal gel: formulation and preliminary clinical study.

Authors:  Manish Maheshwari; Gunjan Miglani; Amita Mali; Anant Paradkar; Shigeo Yamamura; Shivajirao Kadam
Journal:  AAPS PharmSciTech       Date:  2006-09-15       Impact factor: 3.246

5.  A mucoadhesive in situ gel delivery system for paclitaxel.

Authors:  Saurabh Jauhari; Alekha K Dash
Journal:  AAPS PharmSciTech       Date:  2006-06-02       Impact factor: 3.246

6.  Preparation and characterization of pluronic-colloidal silicon dioxide composite particles as liquid crystal precursor.

Authors:  Manish Maheshwari; Anant Paradkar; Shigeo Yamamura; Shivajirao Kadam
Journal:  AAPS PharmSciTech       Date:  2006       Impact factor: 3.246

7.  Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.

Authors:  Di Bei; Jacob Marszalek; Bi-Botti C Youan
Journal:  AAPS PharmSciTech       Date:  2009-08-11       Impact factor: 3.246

8.  Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

Authors:  Di Bei; Jacob Marszalek; Bi-Botti C Youan
Journal:  AAPS PharmSciTech       Date:  2009-08-18       Impact factor: 3.246

9.  Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies.

Authors:  Eder André Estracanholli; Fabíola Silva Garcia Praça; Ana Beatriz Cintra; Maria Bernadete Riemma Pierre; Marilisa Guimarães Lara
Journal:  AAPS PharmSciTech       Date:  2014-07-01       Impact factor: 3.246

10.  Quercetin in lyotropic liquid crystalline formulations: physical, chemical and functional stability.

Authors:  Fabiana T M C Vicentini; Rúbia Casagrande; Waldiceu A Verri; Sandra R Georgetti; M Vitória L B Bentley; Maria J V Fonseca
Journal:  AAPS PharmSciTech       Date:  2008-05-03       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.